Biota Scientific Management Pty Ltd

John Nicholas Lambert

Phillip Dan Cook

Yi Jin

Marija Prhavc

Alistair George Draffan

Silas Bond

Vivek K Rajwanshi

Kandasamy Sakthivel

Vasanthankumar Rajappan

Roland Henry Nearn

Deborah K Ewing, Legal Representative

Jeffrey Peter Mitchell

Paula Francom

Vanessa Anne Sanford

Chin Yu Lim

Gregory J Ewing

Jane Ryan

Vasanthakumar Rajappan

Janet Marie Wilson

Gregory Ewing

The invention relates to the use of bicyclic nucleosides and nucleotides based on formula (II) for the treatment of infectious diseases, and in particular, viral infections.

Bicyclic nucleosides and nucleotides as therapeutic agents

Compounds of formula (I), and their use as in the treatment of infections involving viruses of the Pneumovirinae sub-family (RSV) are disclosed. In the formula ring (A) may be phenyl, pyridyl etc., (B&#x2014;C) may be CH&#x2014;CHetc., (R) may be phenyl and substituted forms thereof, (R) may be assorted substituents. 

Polycyclic agents for the treatment of respiratory syncytial virus infections

Nucelosides and nucleotides containing a tricyclic base portion thereof are useful for treating infectious diseases and proliferative disorders, such as viral infections or cancer respectively.

Tricyclic nucleosides or nucleotides as therapeutic agents

Nucleosides and nucleotides containing a tricyclic base portion thereof are useful for treating infectious diseases and proliferative disorders, such as viral infections or cancer respectively.

Growing community of inventors

Blackburn South, Australia

John Nicholas Lambert